Vivos Therapeutics logo

Vivos Therapeutics share price today

(VVOS)

Vivos Therapeutics share price is $4.24 & ₹363.83 as on 7 Jan 2025, 2.30 'hrs' IST

$4.24

-0.13

(-2.97%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Vivos Therapeutics share price in Dollar and Rupees. Guide to invest in Vivos Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vivos Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Vivos Therapeutics share price movements

  • Today's Low: $4.13
    Today's High: $4.48

    Day's Volatility :7.81%

  • 52 Weeks Low: $1.91
    52 Weeks High: $9.99

    52 Weeks Volatility :80.88%

Vivos Therapeutics Returns

PeriodVivos Therapeutics IncIndex (Russel 2000)
3 Months
81.33%
0.0%
6 Months
80.21%
0.0%
1 Year
-53.76%
0.0%
3 Years
-91.51%
-19.8%

Vivos Therapeutics Key Statistics

in dollars & INR

Previous Close
$4.37
Open
$4.45
Today's High
$4.48
Today's Low
$4.13
Market Capitalization
$25.3M
Today's Volume
$218.7K
52 Week High
$9.99
52 Week Low
$1.91
Revenue TTM
$14.0M
EBITDA
$-12.9M
Earnings Per Share (EPS)
$-4.99
Profit Margin
-85.9%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-284.96%

How to invest in Vivos Therapeutics from India?

It is very easy for Indian residents to invest directly in Vivos Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vivos Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vivos Therapeutics or VVOS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vivos Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vivos Therapeutics shares which would translate to 0.202 fractional shares of Vivos Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vivos Therapeutics, in just a few clicks!

Returns in Vivos Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vivos Therapeutics investment value today

Current value as on today

₹48,090

Returns

₹51,910

(-51.91%)

Returns from Vivos Therapeutics Stock

₹55,132 (-55.13%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Vivos Therapeutics

67%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Vivos Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 67% more investors are searching Vivos Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Vivos Therapeutics

  • Strategic Wealth Designers

    2.07%

  • Geode Capital Management, LLC

    0.60%

  • Omers Administration Corp

    0.52%

  • Commonwealth Equity Services Inc

    0.43%

  • Sabby Management LLC

    0.42%

  • Two Sigma Investments LLC

    0.42%

Analyst Recommendation on Vivos Therapeutics

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Vivos Therapeutics(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Vivos Therapeutics

What analysts predicted

Upside of 48.58%

Current:

$4.24

Target:

$6.30

Insights on Vivos Therapeutics

  • Price Movement

    In the last 3 months, VVOS stock has moved up by 74.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 4.05M → 3.86M (in $), with an average decrease of 4.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.93M → -2.61M (in $), with an average decrease of 35.5% per quarter
  • VVOS vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 55.9% return, outperforming this stock by 109.1%
  • VVOS vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 112.9% return, outperforming this stock by 204.3%
  • Price to Sales

    ForVVOS every $1 of sales, investors are willing to pay $0.6, whereas for Boston Scientific Corp., the investors are paying $8.4 for every $1 of sales.

Vivos Therapeutics Financials in INR & Dollars

FY19Y/Y Change
Revenue
$11.4M
↑ 200.43%
Net Income
$-10.9M
↑ 27.51%
Net Profit Margin
-95.6%
↑ 129.65%
FY20Y/Y Change
Revenue
$13.1M
↑ 14.68%
Net Income
$-8.8M
↓ 19.0%
Net Profit Margin
-67.52%
↑ 28.08%
FY21Y/Y Change
Revenue
$16.9M
↑ 29.23%
Net Income
$-20.3M
↑ 130.0%
Net Profit Margin
-120.18%
↓ 52.66%
FY22Y/Y Change
Revenue
$16.0M
↓ 5.1%
Net Income
$-22.7M
↑ 11.66%
Net Profit Margin
-141.41%
↓ 21.23%
FY23Y/Y Change
Revenue
$13.8M
↓ 13.87%
Net Income
$-13.6M
↓ 40.05%
Net Profit Margin
-98.42%
↑ 42.99%
FY24Y/Y Change
Revenue
$13.8M
↑ 0.0%
Net Income
$-13.6M
↑ 0.0%
Net Profit Margin
-98.42%
↑ 0.0%
Q2 FY23Q/Q Change
Revenue
$3.4M
↓ 11.98%
Net Income
$-5.5M
↓ 215.79%
Net Profit Margin
-162.83%
↓ 286.6%
Q3 FY23Q/Q Change
Revenue
$3.3M
↓ 2.77%
Net Income
$-2.1M
↓ 62.14%
Net Profit Margin
-63.41%
↑ 99.42%
Q4 FY23Q/Q Change
Revenue
$3.2M
↓ 1.61%
Net Income
$-4.3M
↑ 103.49%
Net Profit Margin
-131.13%
↓ 67.72%
Q1 FY24Q/Q Change
Revenue
$3.4M
↑ 5.26%
Net Income
$-3.8M
↓ 11.65%
Net Profit Margin
-110.06%
↑ 21.07%
Q2 FY24Q/Q Change
Revenue
$4.1M
↑ 18.57%
Net Income
$-1.9M
↓ 48.71%
Net Profit Margin
-47.61%
↑ 62.45%
Q3 FY24Q/Q Change
Revenue
$3.9M
↓ 4.79%
Net Income
$-2.6M
↑ 35.54%
Net Profit Margin
-67.77%
↓ 20.16%
FY19Y/Y Change
Profit
$8.7M
↑ 219.38%
FY20Y/Y Change
Profit
$10.4M
↑ 20.28%
FY21Y/Y Change
Profit
$12.6M
↑ 21.04%
FY22Y/Y Change
Profit
$10.0M
↓ 20.51%
FY23Y/Y Change
Profit
$7.7M
↓ 23.65%
FY24Y/Y Change
Profit
$8.3M
↑ 8.12%
Q2 FY23Q/Q Change
Profit
$2.1M
↓ 10.23%
Q3 FY23Q/Q Change
Profit
$1.9M
↓ 9.53%
Q4 FY23Q/Q Change
Profit
$1.8M
↓ 5.74%
Q1 FY24Q/Q Change
Profit
$1.9M
↑ 8.27%
Q2 FY24Q/Q Change
Profit
$2.7M
↑ 36.86%
Q3 FY24Q/Q Change
Profit
$2.3M
↓ 11.96%
FY19Y/Y Change
Operating Cash Flow
$-5.3M
↑ 0.5%
Investing Cash Flow
$86.2K
↓ 107.72%
Financing Cash Flow
$4.5M
↓ 14.93%
FY20Y/Y Change
Operating Cash Flow
$-5.7M
↑ 6.36%
Investing Cash Flow
$-120.3K
↓ 239.47%
Financing Cash Flow
$23.5M
↑ 426.68%
FY21Y/Y Change
Operating Cash Flow
$-15.7M
↑ 177.01%
Investing Cash Flow
$-2.6M
↑ 2068.78%
Financing Cash Flow
$24.2M
↑ 2.68%
Q2 FY23Q/Q Change
Operating Cash Flow
$-2.9M
↓ 19.21%
Investing Cash Flow
$-245.0K
↑ 0.0%
Financing Cash Flow
$0.0
↓ 100.0%

Vivos Therapeutics Technicals Summary

Sell

Neutral

Buy

Vivos Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Vivos Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Vivos Therapeutics Inc
-5.21%
80.21%
-53.76%
-91.51%
-98.06%
Stryker Corporation
-5.14%
7.73%
20.51%
37.02%
70.83%
Boston Scientific Corp.
2.22%
18.53%
55.24%
113.84%
98.4%
Edwards Lifesciences Corp.
4.25%
-20.93%
-2.33%
-38.47%
-5.21%
Abbott Laboratories
-0.93%
11.99%
1.27%
-15.84%
31.69%
Medtronic Plc
-3.59%
5.29%
-6.49%
-23.36%
-31.62%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Vivos Therapeutics Inc
NA
NA
NA
-1.79
-2.85
-0.57
NA
0.22
Stryker Corporation
38.59
38.59
2.51
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
73.82
73.82
1.62
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
28.0
28.0
6.67
2.54
0.19
0.11
NA
16.18
Abbott Laboratories
34.38
34.38
2.19
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
24.43
24.43
1.46
5.45
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Vivos Therapeutics Inc
Buy
$25.3M
-98.06%
NA
-85.9%
Stryker Corporation
Buy
$137.3B
70.83%
38.59
16.34%
Boston Scientific Corp.
Buy
$131.6B
98.4%
73.82
11.26%
Edwards Lifesciences Corp.
Buy
$43.6B
-5.21%
28.0
65.86%
Abbott Laboratories
Buy
$196.2B
31.69%
34.38
13.99%
Medtronic Plc
Buy
$102.4B
-31.62%
24.43
12.06%

About Vivos Therapeutics

vivos therapeutics, inc., a medical technology company, engages in the development and commercialization of technology solutions for patients with sleep disordered breathing (sdb) comprising mild-to-moderate obstructive sleep apnea (osa). the company's solutions cover proprietary alternatives for treating mild-to-moderate osa; craniofacial and anatomical anomalies that are associated with mild-to-moderate osa. its treatment for osa involves specially designed and customized oral appliances and treatment protocols. the company, through its vivos integrated healthcare network, provides access to healthcare providers for delivering care for patients suffering from sleep disordered breathing, including mild-to-moderate osa. vivos therapeutics, inc. also licenses its intellectual property to third-party manufacturers, which fabricate appliance devices for healthcare professionals. it caters to general dentists, medical doctors, myofunctional therapists, chiropractors, healthcare providers,
Organization
Vivos Therapeutics
Employees
114
CEO
Mr. R. Kirk Huntsman
Industry
Miscellaneous

Management People of Vivos Therapeutics

NameTitle
Mr. R. Kirk Huntsman
Co-Founder, Chairman of the Board & CEO
Mr. Bradford K. Amman
CFO, Treasurer & Secretary
Mr. Todd Huntsman
Co-Founder & Senior VP of Product and Technology
Ms. RaeAnn Byrnes
Co-Founder and Senior VP of Events & Clinical Advisory Services
Ms. Susan McCullough
Co-Founder & Executive VP of Operations
Mr. Nicholas M. DeGennaro
Senior Vice President of Medical Integration Division
Ms. Ruth Hembree
Senior Vice President of Practice Services
Ms. Stephanie Huebner
Senior Vice President of Dental Service Integration
Mr. John Ballard
Senior Vice President of Technology

Important FAQs about investing in Vivos Therapeutics from India :

What is Vivos Therapeutics share price today?

Vivos Therapeutics share price today stands at $4.24, Open: $4.45 ; Previous Close: $4.37 ; High: $4.48 ; Low: $4.13 ; 52 Week High: $9.99 ; 52 Week Low: $1.91. The stock opens at $4.45, after a previous close of $4.37. The stock reached a daily high of $4.48 and a low of $4.13, with a 52-week high of $9.99 and a 52-week low of $1.91.

Can Indians buy Vivos Therapeutics shares?

Yes, Indians can invest in the Vivos Therapeutics (VVOS) from India.

With INDmoney, you can buy Vivos Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vivos Therapeutics at zero transaction cost.

How can I buy Vivos Therapeutics shares from India?

It is very easy to buy Vivos Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vivos Therapeutics be purchased?

Yes, you can buy fractional shares of Vivos Therapeutics with INDmoney app.

What are the documents required to start investing in Vivos Therapeutics stocks?

To start investing in Vivos Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Vivos Therapeutics

Today’s highest price of Vivos Therapeutics (VVOS) is $4.48.

Today’s lowest price of Vivos Therapeutics (VVOS) is $4.13.

What is today's market capitalisation of Vivos Therapeutics

Today's market capitalisation of Vivos Therapeutics VVOS is 25.3M

What is the 52 Week High and Low Range of Vivos Therapeutics

  • 52 Week High

    $9.99

  • 52 Week Low

    $1.91

What are the historical returns of Vivos Therapeutics?

  • 1 Month Returns

    -5.21%

  • 3 Months Returns

    80.21%

  • 1 Year Returns

    -53.76%

  • 5 Years Returns

    -98.06%

Who is the Chief Executive Officer (CEO) of Vivos Therapeutics

Mr. R. Kirk Huntsman is the current Chief Executive Officer (CEO) of Vivos Therapeutics.